Albany Molecular Research Inc. (AMRI)
-NasdaqGS 11.71 
0.53(4.74%) 4:00PM EDT|After Hours
:
11.86 0.15 (1.28%) 6:18PM EDT
| Prev Close: | 11.18 |
|---|
| Open: | 11.27 |
|---|
| Bid: | 10.80 x 1000 |
|---|
| Ask: | 11.90 x 100 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 2.05 |
|---|
| Next Earnings Date: | 7-May-13 |
|---|
| Day's Range: | 11.07 - 11.78 |
|---|
| 52wk Range: | 2.25 - 12.14 |
|---|
| Volume: | 375,164 |
|---|
| Avg Vol (3m): | 480,065 |
|---|
| Market Cap: | 356.53M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.13 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Finding Innovative Drugs that are Genuinely Differentiated and Not an Incremental Improvement is the Key to Biotech Success, According to Expert Analyst Boris PeakerWall Street Transcript(Wed, May 1)
- AMRI to Announce First Quarter ResultsPR Newswire(Wed, Apr 24)
- AMRI and Ono Broaden SMARTSOURCING™ CollaborationPR Newswire(Tue, Apr 23)
- AMRI CEO to Present at the 12th Annual Needham Healthcare ConferencePR Newswire(Tue, Apr 23)
- Biotech Stocks Get A Turbo Boost From Vertexat Seeking Alpha(Sat, Apr 20)
- The “Healthy” Play In Contract Research Organizationsat Investopedia(Wed, Apr 17)
- Q1 2013 Value Stock Screen Performance Summaryat Seeking Alpha(Mon, Apr 8)
- 4 Stocks That Have Almost Doubled in 2013at Motley Fool(Tue, Apr 2)
- ALBANY MOLECULAR RESEARCH INC FinancialsEDGAR Online Financials(Fri, Mar 22)
- Risk/Reward For Shares Of Albany Molecular Are Balanced After A 300% Run Up In Sharesat Seeking Alpha(Tue, Mar 19)
- ALBANY MOLECULAR RESEARCH INC Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Mar 18)
- 3 Healthcare Stocks Trading at Attractive Multiplesat Motley Fool(Tue, Mar 12)
- Analysts: Aetna to Meet Targets and 3 New Opinions Investors Must Know Nowat Wall St. Cheat Sheet(Wed, Mar 6)
- AMRI Promotes Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, AsiaPR Newswire(Mon, Feb 25)
- 5 Stocks Surprise Traders After Earningsat Wall St. Cheat Sheet(Mon, Feb 18)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.50 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Albany Molecular Research, Inc., a contract research and manufacturing organization, offers drug discovery, development, and manufacturing services to pharmaceutical and biotechnology companies in the United States, Europe, and Asia.
View More